D.E. Shaw & Co
HCAR

D.E. Shaw & Co’s Healthcare Services Acquisition Corporation Class A Common Stock HCAR Stock Holding History

D.E. Shaw & Co’s Portfolio HCAR Stock Details HCAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,423,957
Closed -$14.2M – 5378
2022
Q3 		$14.2M Buy
1,423,957
+400,000
+39% +$3.96M 0.02% 1086
2022
Q2 		$10.1M Buy
1,023,957
+52,367
+5% +$515K 0.01% 1385
2022
Q1 		$9.52M Sell
971,590
-22,369
-2% -$218K 0.01% 1629
2021
Q4 		$9.7M Buy
+993,959
New +$9.71M 0.01% 1692

D.E. Shaw & Co's HCAR Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Healthcare Services Acquisition Corporation Class A Common Stock (HCAR) in Q4 2022, closing a stake of 1,423,957 shares — an estimated $14.2M sold.

D.E. Shaw & Co first reported a position in HCAR in Q4 2021 and held it in 4 quarters. The position peaked at $14.2M in Q3 2022. 0 funds tracked by Wall St. Rank hold HCAR as of Q4 2022.

  • D.E. Shaw & Co reported no remaining Healthcare Services Acquisition Corporation Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,423,957 Healthcare Services Acquisition Corporation Class A Common Stock shares in Q4 2022, an estimated $14.2M.
  • D.E. Shaw & Co first reported a position in Healthcare Services Acquisition Corporation Class A Common Stock in Q4 2021 and held it in 4 quarters.
  • D.E. Shaw & Co's Healthcare Services Acquisition Corporation Class A Common Stock position peaked at $14.2M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Class A Common Stock as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.